NovaBay Pharmaceuticals Inc. (NBY) Dropped -10.0% or -0.19 To Price $1.71 On Monday


NovaBay Pharmaceuticals Inc. (NBY) dropped -10.0% or -0.19 to $1.71. It is close to 20542 shares traded, which is 67.32% compare to the average total volume 30514. The market cap of NBY is $29.22 million. The year to date change is -63.66%. The 52 week price range is from $1.25 to $4.8. Price of NBY have changed -13.64% during last week. It have changed 5.56% over last month, -22.21% over last 3 months, -41.54% over last 6 months and -59.48% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBY is 1.93. It is 12.87% above current price. The 200-day Moving Averages for NBY is 2.85. It is 66.67% above current price. The 52-week High is 4.8. It is 180.70% from the current price. The 52-week Low is 1.25. It is -26.90% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NBY is 5.61 on 2018-09-14. Short % to float is 0.68%. There are some statistics of NBY. It is has market cap $29.22 million. The share outstanding is 17.09 million. The average volume is 30514. The revenue is 4.09M. The gross profit is 3.57M. The percent of top 15 Institution holding is 0.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBY is -100.70%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBY is -44.85%.


Tags:

Share this post